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ABSTRACT: Human Hint1 suppresses specific gene transcription by inter-
acting with the transcription factor MITF in mast cells. Hint1 activity is con-
nected to lysyl-tRNA synthetase (LysRS), a member of the universal aminoacyl
tRNA synthetase family that catalyzes specific aminoacylation of their cognate
tRNAs, through an aminoacyl adenylate (aa-AMP) intermediate. During im-
mune activation, LysRS produces a side-product diadenosine tetraphosphate
(Ap4A) from the condensation of Lys-AMP with ATP. The pleiotropic signaling
molecule Ap4A then binds Hint1 to promote activation of MITF-target gene
transcription. Earlier work showed that Hint1 can also bind and hydrolyze Lys-
AMP, possibly to constrain Ap4A production. Because Ap4A can result from
condensation of other aa-AMP's with ATP, the specificity of the Hint1 aa-AMP−hydrolysis activity is of interest. Here we show
that Hint1 has broad specificity for adenylate hydrolysis, whose structural basis we revealed through high-resolution structures of
Hint1 in complex with three different aa-AMP analogues. Hint1 recognizes only the common main chain of the aminoacyl
moiety, and has no contact with the aa side chain. The α-amino group is anchored by a cation-pi interaction with Trp123 at the
C-terminus of Hint1. These results reveal the structural basis for the remarkable adenylate surveillance activity of Hint1, to
potentially control Ap4A levels in the cell.
■ INTRODUCTION
Hint1 is a member of a histidine triad (HIT) protein family that
is widespread in eukaryotes and bacteria.
1 Hint1 acts as a haplo-
insufficient tumor suppressor whose deficiency in mice results
in increased susceptibility to both spontaneous and carcinogen-
induced tumor formation.
2,3 Hint1 deficient cells are resistant
to ionizing radiation-induced apoptosis.
4,5 Overexpression of
Hint1 in nonsmall lung cancer cells led to cell growth inhibition
in vitro and to a reduction of tumorigenicity in vivo.
6 Addition-
ally, Hint1 can bind to and has hydrolase activity toward phos-
phoramidates and acyladenylates.
7,8 Hint1 also associates with
and suppresses the microphthalmia transcription factor (MITF)
and the upstream stimulatory factor 2 (USF2).
9,10 How these
activities are associated with Hint1 suppressor function remains
unclear. Interestingly, regulation of Hint1 in mast cells is at
least in part through collaboration with a member of the amino-
acyl tRNA synthetase family.
11−13
Aminoacyl-tRNA synthetases (aaRS's) are essential enzymes
that catalyze the attachment of amino acids onto their cognate
tRNAs in a two-step reaction.
14,15 The amino acid (aa) is first
condensed with ATP to form a tightly bound aminoacyl
adenylate (aa-AMP), and inorganic pyrophosphate (PPi) is
released. The activated aa-AMP is then transferred from the
adenylate to the 3′ end of the tRNA to form aa-tRNA:
++→ ‐ + aa ATP aaRS aaRS(aa AMP) PPi (1)
‐+→ ‐++ aaRS(aa AMP) tRNA aa tRNA AMP aaRS (2)
Some aaRS's also generate a signaling molecule diadenosine
tetraphosphate (AppppA or Ap4A) by catalyzing a side reaction:
16
‐+ → + + aaRS(aa AMP) ATP aa AppppA aaRS (3)
Lysyl-tRNA synthetase (LysRS) is one of the best-known aaRS's
that produces Ap4A.
17−19 Higher eukaryotic LysRS
also joins with eight other aaRS's and three auxiliary proteins
(MSC p43, MSC p38, MSC p18, or named as AIMP1, AIMP2,
AIMP3, respectively) to form a high molecular mass multi-
synthetase complex (MSC).
20−23 Harboring almost half of the
cellular tRNA synthetases, MSC is regarded as a reservoir that
controls the flow of tRNA synthetases between translational and
ex-translational functions.
24,25 For example, in immunologically
activated mast cells, LysRS is released from the MSC, produces
Ap4A, and drives the expression of microphthalmia associated
transcription factor (MITF)-downstream genes that regulate the
immune response.
11,12
Through binding to MITF, Hint1 suppresses MITF activity
in quiescent mast cells.
9 In stimulated mast cells, MITF acti-
vation is accompanied by an increase of intracellular Ap4A,
which promotes dissociation of the Hint1-MITF complex.
9,11
It has been demonstrated that Ap4Ab i n d st oH i n t 1a n d
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26 Addition-
ally, directly adding Ap4A to the cell medium, or siRNA
knockdown of the Ap4A hydrolase, caused dissociation of the
Hint1-MITF complex and activated a subset of MITF-targeted
gene transcription.
11,13,26 It was suggested that LysRS-produced
Ap4A activates MITF by binding and releasing Hint1.
12
Hint1 proteins contain a conserved HxHxHxx motif (x is
hydrophobic) that binds to and hydrolyzes purine-containing
nucleotide derivatives such as adenosine monophosphorami-
date (AMP-NH2), AMP-N-ε-(N-α-acetyl lysine methyl ester)
(AMP-N-ε-lysine), and AMP-N-alanine methyl ester.
27 On the
other hand, Hint1 also hydrolyzes Lys-AMP, the canonical
intermediate product of LysRS (eq 1).
8 Therefore, Lys-AMP
may play a role in the LysRS-Hint1-MITF pathway.
28 For
example, the destruction of Lys-AMP would limit the amount
of Ap4A that can be produced (eq 3 above). In addition,
because 5 mammalian aaRS's (LysRS, ThrRS, SerRS, PheRS,
GlyRS) and more than 10 aaRS's from other species have been
demonstrated to synthesize Ap4A,
18,29−32 and because these
synthetases also synthesize their respective aa-AMP intermedi-
ate, we considered the possibility that the hydrolytic activity of
Hint1 may extend beyond Lys-AMP. Thus, if Ap4A was
generated by various synthetases, then the control of its level
would necessitate a broader specificity for aa-AMP hydrolysis,
either by Hint1 or by one or more other enzymes.
We thus investigated the ability of Hint1 to hydrolyze
adenylates other than Lys-AMP. We showed that Hint1 has
broad specificity for aa-AMP hydrolysis, and does so through a
mechanism that exploits the histidine triad configuration of the
protein. To understand the molecular basis of this broad
specificity, we determined the crystal structures of Hint1 in
complex with a stable Lys-AMP analogue and, separately, with
two other stable aminoacyl adenylate analogues. The results
reveal a new mechanism for binding of aminoacyl adenylates
(aa-AMP's), which is distinct from that seen for the highly
specific complexes of aa-AMP's with their cognate aminoacyl-
tRNA synthetases. Therefore, Hint1 binds and hydrolyzes a
broad array of aa-AMP's, suggesting that the levels of free
adenylates and of Ap4A may be regulated by the Hint1
hydrolytic activity in the cell.
■ RESULTS
Hint1 Reacts with Different aa-AMP's. The intermediate
product of LysRS, Lys-AMP, contains a high-energy ester-
phosphate bond that can be cleaved when dissociated from
LysRS and bound to Hint1. The hydrolysis by Hint1 of LysRS-
generated Lys-AMP can be monitored by the formation of the
Hint1-AMP intermediate.
28 Because Hint1-AMP has a half-life
of ∼0.3 s and is less sensitive to base catalyzed hydrolysis,
8,28 it
represents a transiently modified form of Hint1 that could in
principle also have a specific function distinct from Hint1 itself.
When L-lysine and α-32P-radiolabeled ATP are incubated with
an E. coli LysRS known as LysU, both human and E. coli Hint
hydrolyze Lys-AMP and form the Hint1-AMP intermediate
state that can be detected by SDS-PAGE.
28,33,34 This method
of detection of Hint1-AMP is a definitive way to measure
the ability of Hint1 to react with various aminoacyl-tRNA
synthetase-produced aa-AMP's.
For this purpose, several amino acids (L-Ala, L-Asp, L-Met,
L-His, and L-Lys) with distinct side chains were incubated with
their cognate tRNA synthetase and with human Hint1.
Formation of Hint1-AMP was detected for L-Lys/LysRS, indi-
cating the Lys-AMP generated by LysRS reacts with Hint1 wild
type (WT), and to a lesser extent with an active site mutant
Hint1_H114A (see below) (Figure 1). In addition, formation
of Hint1-AMP was also detected for each other amino acid/
tRNA synthetase pair, with each yielding approximately the
same amount of product within the same time period. Impor-
tantly, no Hint1-AMP was formed when Hint1 was incubated
with the four noncognate tRNA synthetases and L-Lys. This ob-
servation is consistent with the expectation that Hint1 is labeled
by capture of the aa-AMP generated from each tRNA synthe-
tase (Figure 1). Thus, Hint1 binds and reacts with different
aa-AMP's produced by other tRNA synthetases.
Complex Structures of Hint1 with Lys-AMS. Although
the hydrolysis of Lys-AMP by Hint1 was previously
established,
28,35 no detailed understanding of the interaction
of Hint1 with adenylates has been reported. In order to obtain
a structure of a complex, Lys-AMS ([N-(L-lysyl)sulfamoyl]-
adenosine), the nonhydrolyzable analogue of Lys-AMP, was
cocrystallized at a concentration of 5 mM with human Hint1
(Figure 2A). The Hint1/Lys-AMS complex structure was
solved at a resolution of 1.52 Å. Each asymmetric unit in the
crystal contained two Hint1 molecules. As previously observed
in other human Hint1 structures, the two Hint1’s form an ex-
tended β-sheet-like dimer that creates two purine nucleotide-
binding sites.
36,37 Interestingly, only one subunit of the Hint1
dimer bound Lys-AMS. The binding site in the second subunit
of the homodimer was blocked by crystal packing interactions.
The electron density of the ligand could be clearly identified,
including the adenosine moiety, the sulfate-substituted group,
and the N-substituted covalent bond between the lysyl moiety’s
backbone atoms C, Cα, and N and the sulfate. However, no
density for the lysyl side chain could be seen beyond Cβ in the
electron density map (shown at contour level of 1 σ of 2Fo-Fc
map) (Figure 2B). This observation suggests that the side chain
of Lys-AMS adopts a free conformation, such that its electron
density is averaged out in the crystal.
Figure 1. aa-AMP hydrolysis by Hint1 is general. Hint1 was incubated with alpha-32P-ATP, L-lysine, and separately with five different tRNA
synthetases, with/without the cognate amino acids. The reaction was quenched at 1 min and analyzed by SDS-PAGE and autoradiography. Although
lysine is present in each reaction mixture, Hint1-AMP only forms when LysRS is present, or when there is another tRNA synthetase with its cognate
amino acid. An active site mutant Hint1_H114A, which was characterized in this work, was also used to coincubate with LysRS and L-Lys.
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aa-AMP Analogues. The Hint1/Lys-AMS structure showed
that Hint1 only recognized the main chain of the lysyl group.
The α-amino group of the lysyl backbone is placed on top of
Trp123 of Hint1. Because the amino group is likely to be
protonated under the conditions of crystallization (pH 7.5), at
the close distance of 3.5 Å, it forms a cation-pi interaction with
the aromatic side chain of Trp123.
38 With lateral support from
the side chains of Gln47, Arg95, Val97, and Leu116, and from
Pro125 from the back, the indole side chain of Trp123 forms a
rigid wall for the lysyl-binding pocket (rmsd of 0.3 Å between
the structure of the apoprotein and of the Lys-AMS complex)
(Figure 3A).
37 Consistent with the important role of Trp123
for recognizing the lysyl backbone, mutation of Trp123 to Ala
showed both a lag in the formation of Hint1-AMP and a de-
crease in the total amount of Hint1-AMP that was generated
(Figure 3C). In addition, the carbonyl group of the lysyl moiety
formed one hydrogen bond with the side chain of N99, to-
gether with two internal hydrogen bonds with the α-amino group
of the lysyl and sulfate groups. The N-substituted oxygen of Lys-
AMS also formed hydrogen bonds with Ser107, Gly105, and
Asn99. Thus, Lys-AMS is bound at a defined position in Hint1.
Because of the confined binding pocket shaped by Trp123,
the side chain of Lys-AMS is oriented toward the solvent
(Figure 3A). Having no interaction with Hint1, the side chain
of the lysyl moiety is free to rotate and therefore is completely
disordered in the crystal. For this reason, we speculated that
Hint1 would not be specific to Lys-AMP and would likely bind
different aa-AMP's from other tRNA synthetases.
To test this hypothesis, we crystallized Hint1 in complex
with two other aminoacyl-AMP analogues, i.e., Ala-AMS and
Trp-AMS. Consistent with expectations, the electron density of
the tryptophanyl side chain was not seen in the Trp-AMS com-
plex with Hint1 (Figure 2D). Only the adenylate moiety, the
main chain, and the Cβ of the side chain of Trp-AMS had clear
electron densities. These densities resembled the electron den-
sities of Ala-AMS within its Hint1 complex (Figure 2C). Thus,
the three crystal structures of the Hint1/aa-AMS complexes
suggest that the side chain of aa-AMP is not recognized by Hint1.
Mechanism of Lys-AMP Hydrolysis by Hint1. Several
structures of mammalian Hint1 in apo-form, in complex with
AMP (one of the products of adenylate hydrolysis), GMP, the
substrate analogue AMPCP, and the transition state analogue
adenosine-5′-ditungstate have been reported.
36,37,39,40 Struc-
tural comparisons showed that the AMS moiety of Lys-AMS
(with sulfur substitution of the phosphate) occupied the same
position as AMP in the Hint1/AMP complex. The sulfate
group of Lys-AMS binds to two (His112, His114) of the three
characteristic histidines in Hint1 (Figure 3A). Previous results
showed that adenosine and sodium tungstate formed a cova-
lently linked complex (adenosine-5′-ditungstate) with Hint1.
36
The tungstate ion reacted with the imidazole side chain of
His112 of Hint1 through a pentacovalent complex with the Nε
of His112, to thus mimic the transient Hint1-AMP-P complex.
Superimpositions of the different Hint1 complexes showed that
the sulfur atom of Lys-AMS is at the position equivalent to the
α-phosphorus atom of AMPCP in the substrate analogue com-
plex (0.4 Å distance). This sulfur is also close to the tungsten
atom in the adenosine-5′-ditungstate complex (distance of 0.4 Å,
Figure 3B). In addition, the sulfate of Lys-AMS interacts with
His114 and Asn99, both of which are conserved in Hint1 proteins
(Figure 3B,D). Thus, Lys-AMS binds to Hint1 in a productive
manner for hydrolysis, and the Hint1/Lys-AMS structure appears
to recapitulate the bound conformation for native Lys-AMP.
Hydrolysis of Lys-AMP is likely through the same mech-
anism that Hint1 hydrolyzes other substrates, such as ADP
or AMP-NH2.
27,28,36 Binding of Lys-AMP initiates an in-line
attack on the α phosphate by histidine (His112) as the nucleophile
Figure 2. Complex structure of human Hint1 with Lys-AMS, Ala-AMS, and Trp-AMS. (A) Dimeric structure of Hint1 in complex with Lys-AMS.
One subunit of the Hint1 dimer contains the ligand. (B−D) Electron density maps of the bound aa-AMS analogues. The refined 2Fo-Fc density
maps are shown at 1.0 σ. Chemical structures of the analogues are shown on the right, with electron densities missing from the side chains
highlighted by shading on the chemical structures.
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dx.doi.org/10.1021/jp212457w | J. Phys. Chem. B 2012, 116, 6798−6805 6800Figure 3. Hydrolysis of Lys-AMP by Hint1. (A) Detailed interaction of Lys-AMS with human Hint1. The α-amino group of the lysyl group in Lys-
AMS forms a cation-π interaction with the aromatic ring of Trp123. (B) Structural superimposition of Hint1/Lys-AMS with the transition state
complex of Hint1/adenosine-5′-ditungstate (Ade-W2O6, PDB 6FIT). The sulfate group of Lys-AMS is located close to the α tungstate group of
Ade-W2O6. A yellow dashed line indicates the covalent bond formed between the α tungsten (brown) and Nε of the H112 side chain. The
overlapped adenosine moieties of these two ligands are not shown. (C) Formation of the covalent Hint1-AMP intermediate shows the important
role of H114 and W123 for hydrolysis of Lys-AMP. The reaction conditions are as described in the legend to Figure 1. (D) Sequence alignment of
vertebrate HINT proteins. Critical residues involved in the binding and hydrolysis of aa-AMP's are boxed in red, and are conserved in Hint1’s and its
Hint2 paralogs (which function in mitochondria). Different residues are found in Hint3's, whose function is less characterized.
52 (E) Catalytic
mechanism proposed for the hydrolysis of aa-AMP's by human Hint1.
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phosphate position (as also seen in the amino acid activa-
tion step by tRNA synthetases).
36,41 Next, AMP is covalently
linked to His112 of Hint1 to form a nucleotidyl phosphopro-
tein (Hint1-AMP) intermediate, and lysine is subsequently re-
leased. Finally, AMP is hydrolyzed from Hint1 by a water
molecule probably facilitated by Ser107.
40 The other conserved
His residue (His114) forms an electron transfer chain between
His51 and the sulfate group of Lys-AMS (Figure 3A,B,E), and
may thereby help to stabilize the transition state. Mutating this
His residue (His114) to Ala dramatically decreased the amount
of Hint1-AMP that was formed, thus supporting the idea that
His114 is also a critical residue for the hydrolysis of Lys-AMP
(Figure 3C). Importantly, binding and hydrolysis of Lys-AMP
involves only the recognition of AMP and the lysyl backbone.
Therefore, this hydrolysis mechanism would be applicable to
aa-AMP's generated from other aaRS's (Figure 3E).
■ DISCUSSION
Trp123 Has an Important Role for Substrate
Recognition by Hint1. Hint1 is a member of the HIT super-
family that is divided into many branches including the Hint
branch, the fragile histidine triad (Fhit) branch, and the
galactose-1-phosphate uridyltransferase (GalT) branch.
42 Each
branch has a different substrate specificity.
27 In contrast to Fhit,
which hydrolyzes diadenosine-polyphosphates (such as Ap3A),
Hint1 shows weak activity toward ADP (kcat of 10−3 s−1 and Km
of 800 μM) and no activity toward other nucleotides with
multiple phosphates such as ATP and ApnA( n =3 −5).
36 On
the other hand, Hint1 preferentially binds and hydrolyzes aden-
osine derivatives with a single phosphate, including phosphor-
amidates (e.g., AMP-NH2, AMP-N-Ala, AMP-N-ε-Lys,) and
acyl adenylates (e.g., Lys-AMP), and has turnover rates kcat as
high as ∼2s −1 and Km values as low as ∼0.1 μM.
34,39 Except for
the characteristic AMP-binding pocket in Hint1, the structures
of the Hint1/aa-AMS complexes showed that the main chain of
the aminoacyl group was placed into a groove formed by
Trp123. The α-amino group of the aminoacyl moiety stacked
on top of the imidazole side chain of Trp123, by forming a
cation-pi interaction (Figure 2). Similar interactions are also
found in the amino acid binding pocket of AlaRS and SerRS,
where a strictly conserved Trp residue supports the backbone
of the bound amino acid.
41,43 (Presumably, a phosphate group
in ADP or ApnA at the position of the α-amino group will form
a less favorable interaction with Trp123, and this circumstance
would give a lower affinity for Hint1.) However, for AlaRS and
SerRS, and unlike Hint1, there are also specific interactions and
pockets for the alanyl and seryl side chains.
Interestingly, Trp123 is located at the C-terminus of human
Hint1 (126 residues) and is one of the 15 residues that are
sexually dimorphic in avian HINT-related genes, which were
suggested to be responsible for feminization.
44 Recent bio-
chemical studies established an important role for the C-terminus
of Hint1. Swapping of the C-terminal seven residues of human
Hint1 to E. coli Hint changed the substrate specificity.
33 In
addition, deletion of three C-terminal residues abolished the
ability of E. coli Hint to hydrolyze Lys-AMP. However, the
deletion only had a modest effect on acyl-adenylate substrates
that do not contain the aminoacyl backbone.
35 In the structure
of rabbit Hint1 in complex with an AMP-N-ε-Lys analogue,
Trp123 interacts with the alkyl portion of the lysyl leaving
group.
39 Substitution of Trp123 to Gln, which is present in
female-specific avian HINT-related genes, reduced kcat/Km for
AMP-N-ε-lysine hydrolysis by 17-fold.
44 Consistent with these
results, our work showed that the Trp123Ala mutation at the
C-terminus of Hint1 caused a dramatic loss of activity in
forming the human Hint1-AMP intermediate, and there-
by emphasized the importance of Trp123 in the hydrolysis of
Lys-AMP.
General Specificity of Hint1 for aa-AMP's. In the struc-
tures of Hint1/aa-AMS complexes, the aminoacyl backbone of
Lys-AMS (or Ala-AMS, Trp-AMS) was oriented toward the
outside of Hint1 (Figure 4). The interaction mode between
Hint1 and Lys-AMP contrasts with that of the LysRS/Lys-AMP
Figure 4. Recognition of Lys-AMP by Hint1 vs LysRS. The Lys-AMS binding pocket of human Hint1 in comparison with the pocket of LysRS (PDB
1E1T) shows side chain independent recognition of Lys-AMP by Hint1. Residues responsible for recognition of the lysyl-AMS in Hint1 and LysRS
are depicted. The potential direction of the Lys side chain in the Hint1/Lys-AMS structure is shown as a dashed line.
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AMP, or with L-lysine and ATP.
45,46 In order to recognize
lysine and attach it to the cognate tRNALys, LysRS forms a deep
pocket that specifically accommodates only lysine. Two strictly
conserved glutamic acid side chains (Glu240 and Glu428 in
E. coli LysU and Glu301 and Glu501 in human LysRS) are located
at the end of the pocket, where they recognize the ε-amino of
the lysine side chain (Figure 4B). Also different from the
cation-pi interaction in Hint1, the α-amino group of the lysyl
moiety is anchored by hydrogen bonds with two Glu’s in LysRS
(Glu240 and Glu278 in LysU and Glu301 and Glu339 in hu-
man LysRS). The carboxyl group of the lysyl moiety interacts
with the characteristic Arg262 in LysU and is positioned to
react with the α-phosphate group of ATP. Comparison of the
Hint1/Lys-AMS and LysRS/Lys-AMS cocrystal structures
shows that the Lys-AMS pockets in these two proteins are in
opposite directions. While in LysRS the lysyl moiety is facing
inside and AMP/ATP faces outside, AMP is inside and the lysyl
group is facing outside in Hint1 (Figure 4). Similarly, the ligand
electron densities in the structures of Hint1 with Ala-AMS and
Trp-AMS also show that no side chain of any aminoacyl group
is involved in an interaction with Hint1 (Figure 2).
An important link between Hint1 and aaRS's was found dur-
ing the immune activation of mast cells, where LysRS contrib-
uted to an ∼3-fold increase of intracellular Ap4A.
12 Earlier work
showed that Ap4A binding to Hint1 could dissociate the Hint1-
MITF complex. This effect appears to be specific because other
ApnA( n = 3, 5) did not cause dissociation.
11 Lys-AMP, with a
size between Ap3A and AMP, is less likely to dissociate the
Hint1-MITF interaction. In addition, because the hydrolysis
product AMP could not dissociate the Hint1-MITF interaction,
the hydrolysis of Lys-AMP by Hint1 may also alleviate the
effect of Lys-AMP.
11 On the other hand, the adenylation of
Hint1 by AlaRS, MetRS, HisRS, and AspRS shows that Hint1
hydrolyzes various aa-AMP's (Figure 1). Binding and hydrolysis
of aa-AMP's by Hint1 is through a common mechanism, as
evidenced by the formation of the Hint1-AMP intermediate
with all tested aaRS's. This broad activity of human Hint1 to
bind and hydrolyze aa-AMP's is caused by the unique binding
pocket involving Trp123, which is conserved in Hint1 proteins
from C. elegans to human.
1 With more than half of the aaRS
members including LysRS, AlaRS, and MetRS known to syn-
thesize Ap4A in vitro and/or in cells,
18,30,47 Hint1 may have a
general ability to constrain the formation of Ap4A by the aaRS
family. In addition, we cannot rule out the possibility that the
transient Hint1-AMP complex, and complexes of Hint1 with
other aminoacyl adenylates, also play a role in regulating the
functions of Hint1.
■ METHODS
Protein Preparation. The gene encoding human Hint1
was synthesized by codon optimization. Human Hint1 was con-
structed with a N-terminal 6xHis-tag with a TEV protease
cleavage site in a pHisTEV vector. Human Hint1 was expressed
in the bacterial strain BL21(DE3) at 16 °C for 20 h and puri-
fied to homogeneity with a Ni-HiTrap affinity column (GE
Healthcare, Piscataway, NJ). The 6xHis-TEV tag was cleaved
by TEV protease, and the nontagged Hint1 was further purified
by a HiTrap SP Sepharose column (GE Healthcare, Piscataway,
NJ). It was concentrated to 50 mg/mL in a final buffer (10 mM
Table 1. Data Collection and Refinement Statistics
Hint1/Ala-AMS Hint1/Lys-AMS Hint1/Trp-AMS
Data Collection
space group C2 C2 C2
cell dimensions
a, b, c (Å) 78.31, 46.37, 64.11 79.00, 46.41, 64.23 79.00, 46.43, 63.88
α, β, γ (deg) 90.00, 95.02, 90.00 90.00, 95.46, 90.00 90.00, 95.24, 90.00
resolution (Å) 50.00−1.52 (1.57−1.52)
a 25.00−1.52 (1.57−1.52) 25.00−1.67 (1.73−1.67)
Rsym or Rmerge (%) 3.9 (11.5) 4.8 (29.9) 5.3 (48.9)
I/sI 42.5 (16.8) 38.96 (6.4) 35.2 (3.4)
completeness (%) 98.4 (97.1) 99.3 (98.2) 98.4 (96.7)
redundancy 7.5 (6.7) 7.5 (6.5) 7.5 (7.3)
Refinement
resolution (Å) 50.00−1.52 (1.56−1.52) 25.00−1.52 (1.56−1.52) 25.00−1.67 (1.74−1.67)
no. reflections 34772 34771 25244
Rwork/Rfree (%) 14.1/16.4 14.2/16.2 14.4/17.3
no. atoms
protein 1826 1805 1788
ligand 28 28 28
solvent 306 300 302
B-factors (Å2)
protein 12.11 13.98 13.95
ligand 16.07 19.25 26.33
solvent 28.20 31.48 31.42
rms deviations
bond lengths (Å) 0.007 0.008 0.009
bond angles (deg) 1.242 1.189 1.250
Ramachandran plot
most favored (%) 98.8% 98.7% 98.7%
additional allowed (%) 1.2% 1.3% 1.3%
aValues in parentheses are for the highest-resolution shell.
The Journal of Physical Chemistry B Article
dx.doi.org/10.1021/jp212457w | J. Phys. Chem. B 2012, 116, 6798−6805 6803Tris−HCl, pH 8.0, 50 mM NaCl) for crystallization. Full-length
AlaRS, AspRS, HisRS, and MetRS were cloned from the E. coli
genome K12 and were inserted into pET vectors (Novagen,
Darmstadt, Germany) with the 6xHis-tag. These proteins were
expressed in the bacterial strain BL21(DE3) (NEB, Ipswich,
MA) at 37 °C for 6 h and purified to homogeneity with the
Ni-HiTrap affinity column.
Crystallization, Data Collection, and Structure Refine-
ment. Crystallization was done by the sitting drop method.
Protein solution (nontagged recombinant human Hint1 (see
above)) was preincubated with 5 mM Lys-AMS, Ala-AMS, or
Trp-AMS for 10 min at 22 °C. A drop was prepared by mixing
0.5 μL of protein solution with 0.5 μL of precipitant solution,
containing 25−28% PEG3350, 100 mM HEPES pH 7.5, and
was equilibrated against 90 μL of precipitant solution. Crystals
were collected after incubation at 18 °C for 3−7 days and were
flash-frozen in liquid nitrogen for data collection.
Three data sets were obtained from Beamline 11-1 at the
Stanford Synchrotron Radiation Laboratory (Menlo Park, CA).
The crystals belong to space group C2 with two molecules of
Hint1 per asymmetric unit. The structures were solved by
molecular replacement using the Hint1 apo structure (PDB
6RHN) with the program Molrep.
48 Iterative model building
and refinement were performed by using Coot and Phenix.
49,50
Data collection and refinement statistics are given in Table 1.
Enzymatic Assays. All assays for Hint1-AMP formation
were carried out in a standard buffer (50 mM Hepes-Na, pH
7.5, 20 mM KCl, 10 mM MgCl2, 2 mM DTT, 0.16 μM α-32P-
ATP, 3 μg/mL inorganic pyrophosphatase, and 100 μM amino
acid) at 22 °C. Wild-type or mutant Hint1 (0.5 μM) was
coincubated with human LysRS,
51 or E. coli AlaRS, AspRS,
HisRS, or MetRS (0.5 μM). The reaction was quenched at each
time point by adding equal amounts of 2× SDS-PAGE sample
buffer and boiled for 5 min at 95 °C. Equal amounts of each
sample were load onto a 4−20% SDS-PAGE gel, which ran to
the point that most of the free ATP was eluted from the gel.
Radioactive bands of Hint1 and AMP were detected by
phosphoimaging (Molecular Imager FX, Biorad, Hercules, CA)
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